SEC Company Response from ABBOTT LABORATORIES (ABT) — Dec 7, 2010
ABBOTT LABORATORIES
Date: Dec. 7, 2010 · CIK: 0000001800 · Accession: 0000903423-10-000689
AI Filing Summary & Sentiment
File numbers found in text: 001-02189
Letter
Division of Corporation Finance United States Securities and Exchange Commission Re: Abbott Laboratories Form 10-K for Year Ended December 31, 2009 Definitive Proxy Statement on Schedule 14A Filed March 15, 2010 (File No. 001-02189)
Dear Mr. Reidler:
This responds to your letter of November 19, 2010, addressed to Mr. Thomas C. Freyman of Abbott Laboratories, providing comments with respect to the disclosures made by Abbott in the referenced filings. This confirms our conversation in which I advised you, on behalf of our client, that Abbott will provide a response to the Commission on or before December 10, 2010.
Very truly yours,
Arthur H. Kohn
Show Raw Text
CORRESP
1
filename1.htm
Unassociated Document
Writer’s Direct Dial: +1 212 225 2920
E-Mail: akohn@cgsh.com
December 7, 2010
Mr. Jeffrey Reidler
Assistant Director
Division of Corporation Finance
United States Securities and Exchange Commission
Mail Stop 4720
100 F Street, NE
Washington, D.C. 20549
Re: Abbott Laboratories
Form 10-K for Year Ended December 31, 2009
Definitive Proxy Statement on Schedule 14A Filed March 15, 2010
(File No. 001-02189)
Dear Mr. Reidler:
This responds to your letter of November 19, 2010, addressed to Mr. Thomas C. Freyman of Abbott Laboratories, providing comments with respect to the disclosures made by Abbott in the referenced filings. This confirms our conversation in which I advised you, on behalf of our client, that Abbott will provide a response to the Commission on or before December 10, 2010.
Very truly yours,
Arthur H. Kohn